| Authors: |
Cass SH; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA., Tobin JWD; Haematology Department, Princess Alexandra Hospital, Woolloongabba; University of Queensland, Brisbane, Australia., Seo YD; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA., Gener-Ricos G; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston., Keung EZ; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA., Burton EM; Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Davies MA; Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., McQuade JL; Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Lazar AJ; Departments of Pathology and Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, USA., Mason R; Gold Coast University Hospital, Southport., Millward M; University of Western Australia, Perth., Sandhu S; Peter Macallum Cancer Centre, Melbourne., Khoo C; Peter Macallum Cancer Centre, Melbourne., Warburton L; Fiona Stanley Hospital, Perth; Edith Cowan University, Joondalup; Future Health Research and Innovation Fund/Raine Clinician Research Fellowship., Guerra V; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston., Haydon A; Alfred Hospital, Melbourne., Dearden H; Melanoma Institute Australia, The University of Sydney, Sydney., Menzies AM; Melanoma Institute Australia, The University of Sydney, Sydney; Faculty of Medicine and Health, The University of Sydney, Sydney; The University of Sydney Charles Perkins Centre, Sydney; The University of Sydney Royal North Shore and Mater Hospitals, Sydney., Carlino MS; Melanoma Institute Australia, The University of Sydney, Sydney; Westmead Hospital, Sydney, Australia., Smith JL; Westmead Hospital, Sydney, Australia., Mollee P; Haematology Department, Princess Alexandra Hospital, Woolloongabba; University of Queensland, Brisbane, Australia., Burgess M; Haematology Department, Princess Alexandra Hospital, Woolloongabba; University of Queensland, Brisbane, Australia., Mapp S; Haematology Department, Princess Alexandra Hospital, Woolloongabba; University of Queensland, Brisbane, Australia., Keane C; Haematology Department, Princess Alexandra Hospital, Woolloongabba; University of Queensland, Brisbane, Australia., Atkinson V; Haematology Department, Princess Alexandra Hospital, Woolloongabba; University of Queensland, Brisbane, Australia., Parikh SA; Mayo Clinic, Rochester, USA., Markovic SN; Mayo Clinic, Rochester, USA., Ding W; Mayo Clinic, Rochester, USA., Call TG; Mayo Clinic, Rochester, USA., Hampel PJ; Mayo Clinic, Rochester, USA., Long GV; Melanoma Institute Australia, The University of Sydney, Sydney; Faculty of Medicine and Health, The University of Sydney, Sydney; The University of Sydney Charles Perkins Centre, Sydney; The University of Sydney Royal North Shore and Mater Hospitals, Sydney., Wargo JA; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: jwargo@mdanderson.org., Ferrajoli A; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston. |
